Bennett C, Rivers EJ, Woo W, Bloch M, et al. Immunogenicity and Safety of Heterologous Omicron BA.1 and Bivalent SARS-CoV-2 Recombinant Spike Protein Booster Vaccines: A Phase 3 Randomized Clinical Trial. J Infect Dis 2024;230:e4-e16.
PMID: 39052718